Pfizer-BioNTech Prepare to Revise Vaccine Formula for Omicron Variant

January 26, 2022 by Alexa Hornbeck
<strong>Pfizer-BioNTech Prepare to Revise Vaccine Formula for Omicron Variant</strong>

On Tuesday, Pfizer-BioNTech announced they will begin a clinical trial to develop an omicron-specific COVID-19 vaccine candidate. 

“Emerging data indicate vaccine-induced protection against infection and mild to moderate disease wanes more rapidly than was observed with prior strains,” said Prof. Ugur Sahin, CEO and co-founder of BioNTech, in a press release.

To conduct the clinical trial, 1,420 participants between the ages of 18 and 55 will be enrolled and placed into three cohorts — those who have received two doses of the current Pfizer vaccine, those who received three doses, and those who have not received any vaccine doses — at least 90 to 180 days prior to the study.

Each of these three cohorts will receive between one to three shots of a 30-microgram dose of the omicron-specific vaccine. Researchers will then evaluate whether a variant-based vaccine can achieve a similar level of protection against omicron as it did with earlier variants, but with a longer duration of protection.

Pfizer-BioNTech also released new findings this week showing results from two laboratory studies that demonstrate three doses of the Pfizer vaccine elicited antibodies that neutralize the omicron variant for about four months after the third dose, and the company still expects to produce 4 billion doses in 2022.

Alexa can be reached at [email protected] 

A+
a-

In The News

Health

Voting

Health

Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

News From The Well
scroll top